Cargando…

Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency

BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zifei, Sun, Song, Ji, Min, Shi, Peng, Wang, Yuhuan, Huang, Zhiheng, Huang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661559/
https://www.ncbi.nlm.nih.gov/pubmed/37986047
http://dx.doi.org/10.1186/s12876-023-03051-4
_version_ 1785148470851534848
author Tang, Zifei
Sun, Song
Ji, Min
Shi, Peng
Wang, Yuhuan
Huang, Zhiheng
Huang, Ying
author_facet Tang, Zifei
Sun, Song
Ji, Min
Shi, Peng
Wang, Yuhuan
Huang, Zhiheng
Huang, Ying
author_sort Tang, Zifei
collection PubMed
description BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R signaling deficiency. METHODS: The medical records of all patients undergoing enterostomy for signaling deficiency were retrospectively assessed during 2012.1–2022.7 in a tertiary teaching hospital, Children’s Hospital of Fudan University, Shanghai, China. Data on disease history, diagnosis and details of enterostomy and stoma closure and follow-up were collected. Univariate and multivariate logistic regression analyses were used to evaluate the risk factors associated with the long-term outcome of delayed stoma closure. RESULTS: A total of 46 patients underwent an enterostomy, 19 who required emergency enterostomy and 27 with selective enterostomy. After ten years of follow-up, 35 patients underwent hematopoietic stem cell transplantation (HSCT), and 25 patients were alive after HSCT. The median timeframe between HSCT and stoma closure was 19.6 [15.9,26.2] months. Nineteen patients underwent stoma closure and had an average age of 3.9 ± 1.5 years; 6 patients were waiting for stoma closure. Based on a univariate logistic model, risk factors significantly associated with late stoma closure were age at enterostomy and age at HSCT. However, multivariate logistic regression showed no statistically significant factor associated with late stoma closure. There was no significant difference between the stoma closure group and delay closure group in the z scores of weight for age at follow up. CONCLUSIONS: This study determined the long-term outcomes after enterostomy for VEOIBD with interleukin-10 signaling deficiency. The appropriate time point of enterostomy and HSCT may improve quality of life in the long term.
format Online
Article
Text
id pubmed-10661559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106615592023-11-20 Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency Tang, Zifei Sun, Song Ji, Min Shi, Peng Wang, Yuhuan Huang, Zhiheng Huang, Ying BMC Gastroenterol Research BACKGROUND: Very early-onset inflammatory bowel disease (VEOIBD) with interleukin-10 (IL10R) signaling deficiency usually requires enterostomy in patients who are refractory to traditional treatment. This study aimed to evaluate long-term outcomes after enterostomy for VEOIBD patients with IL10R signaling deficiency. METHODS: The medical records of all patients undergoing enterostomy for signaling deficiency were retrospectively assessed during 2012.1–2022.7 in a tertiary teaching hospital, Children’s Hospital of Fudan University, Shanghai, China. Data on disease history, diagnosis and details of enterostomy and stoma closure and follow-up were collected. Univariate and multivariate logistic regression analyses were used to evaluate the risk factors associated with the long-term outcome of delayed stoma closure. RESULTS: A total of 46 patients underwent an enterostomy, 19 who required emergency enterostomy and 27 with selective enterostomy. After ten years of follow-up, 35 patients underwent hematopoietic stem cell transplantation (HSCT), and 25 patients were alive after HSCT. The median timeframe between HSCT and stoma closure was 19.6 [15.9,26.2] months. Nineteen patients underwent stoma closure and had an average age of 3.9 ± 1.5 years; 6 patients were waiting for stoma closure. Based on a univariate logistic model, risk factors significantly associated with late stoma closure were age at enterostomy and age at HSCT. However, multivariate logistic regression showed no statistically significant factor associated with late stoma closure. There was no significant difference between the stoma closure group and delay closure group in the z scores of weight for age at follow up. CONCLUSIONS: This study determined the long-term outcomes after enterostomy for VEOIBD with interleukin-10 signaling deficiency. The appropriate time point of enterostomy and HSCT may improve quality of life in the long term. BioMed Central 2023-11-20 /pmc/articles/PMC10661559/ /pubmed/37986047 http://dx.doi.org/10.1186/s12876-023-03051-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tang, Zifei
Sun, Song
Ji, Min
Shi, Peng
Wang, Yuhuan
Huang, Zhiheng
Huang, Ying
Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title_full Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title_fullStr Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title_full_unstemmed Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title_short Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
title_sort long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661559/
https://www.ncbi.nlm.nih.gov/pubmed/37986047
http://dx.doi.org/10.1186/s12876-023-03051-4
work_keys_str_mv AT tangzifei longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT sunsong longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT jimin longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT shipeng longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT wangyuhuan longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT huangzhiheng longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency
AT huangying longtermoutcomesafterenterostomyforveryearlyonsetinflammatoryboweldiseasewithinterleukin10signalingdeficiency